Author:
Sanga Shamita,Chakraborty Sudipta,Bardhan Mainak,Polavarapu Kiran,Kumar Veeramani Preethish,Bhattacharya Chandrika,Nashi Saraswati,Vengalil Seena,Geetha Thenral S.,Ramprasad Vedam,Nalini Atchayaram,Basu Analabha,Acharya Moulinath
Abstract
AbstractSarcoglycanopathy is the most frequent form of autosomal recessive limb-girdle muscular dystrophies caused by mutations in SGCB gene encoding beta-sarcoglycan proteins. In this study, we describe a shared, common haplotype co-segregating in 14 sarcoglycanopathy cases from 13 unrelated families from south Indian region with the likely pathogenic homozygous mutation c.544 T > G (p.Thr182Pro) in SGCB. Haplotype was reconstructed based on 10 polymorphic markers surrounding the c.544 T > G mutation in the cases and related family members as well as 150 unrelated controls from Indian populations using PLINK1.9. We identified haplotype H1 = G, A, G, T, G, G, A, C, T, G, T at a significantly higher frequency in cases compared to related controls and unrelated control Indian population. Upon segregation analysis within the family pedigrees, H1 is observed to co-segregate with c.544 T > G in a homozygous state in all the pedigrees of cases except one indicating a probable event of founder effect. Furthermore, Identical-by-descent and inbreeding coefficient analysis revealed relatedness among 33 new pairs of seemingly unrelated individuals from sarcoglycanopathy cohort and a higher proportion of homozygous markers, thereby indicating common ancestry. Since all these patients are from the south Indian region, we suggest this region to be a primary target of mutation screening in patients diagnosed with sarcoglycanopathy.
Funder
Council of Scientific and Industrial Research (CSIR), Govt. of India
Indian Council of Medical Research (ICMR), Govt. of India
Publisher
Springer Science and Business Media LLC